Temozolomide as Second or Third Line Treatment of Patients with Neuroendocrine Carcinomas

Background. Knowledge of the clinical efficacy in recurrent neuroendocrine carcinomas is sparse. Treatment with temozolomide alone or in combination with capecitabine and bevacizumab has recently shown promising results. Patients and Methods. Analysis of consecutive patients with neuroendocrine carc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Olsen, Ingrid H., Sørensen, Jens B., Federspiel, Birgitte, Kjaer, Andreas, Hansen, Carsten P., Knigge, Ulrich, Langer, Seppo W.
Format: Artigo
Sprog:Inglês
Udgivet: The Scientific World Journal 2012
Fag:
Clinical Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3432352/
https://ncbi.nlm.nih.gov/pubmed/22973169
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1100/2012/170496
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker